Citigroup’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.4K Sell
4,200
-4,859
-54% -$51.4K ﹤0.01% 4093
2025
Q1
$136K Sell
9,059
-1,169
-11% -$17.6K ﹤0.01% 3647
2024
Q4
$168K Sell
10,228
-1,295
-11% -$21.3K ﹤0.01% 3684
2024
Q3
$285K Buy
11,523
+8,168
+243% +$202K ﹤0.01% 3350
2024
Q2
$85K Buy
3,355
+504
+18% +$12.8K ﹤0.01% 3569
2024
Q1
$72.4K Buy
2,851
+724
+34% +$18.4K ﹤0.01% 3704
2023
Q4
$48.2K Buy
2,127
+2,036
+2,237% +$46.1K ﹤0.01% 3795
2023
Q3
$1.7K Sell
91
-19,925
-100% -$371K ﹤0.01% 4246
2023
Q2
$520K Sell
20,016
-11,465
-36% -$298K ﹤0.01% 2712
2023
Q1
$904K Buy
31,481
+8,885
+39% +$255K ﹤0.01% 2090
2022
Q4
$669K Sell
22,596
-11,784
-34% -$349K ﹤0.01% 2342
2022
Q3
$818K Buy
34,380
+9,442
+38% +$225K ﹤0.01% 2242
2022
Q2
$557K Buy
24,938
+3,559
+17% +$79.5K ﹤0.01% 2517
2022
Q1
$537K Sell
21,379
-11,653
-35% -$293K ﹤0.01% 2802
2021
Q4
$1.18M Buy
33,032
+12,356
+60% +$443K ﹤0.01% 2391
2021
Q3
$880K Sell
20,676
-25,402
-55% -$1.08M ﹤0.01% 2488
2021
Q2
$2M Buy
46,078
+4,330
+10% +$187K ﹤0.01% 2107
2021
Q1
$1.7M Buy
41,748
+32,316
+343% +$1.32M ﹤0.01% 2030
2020
Q4
$427K Buy
9,432
+2,542
+37% +$115K ﹤0.01% 2735
2020
Q3
$244K Sell
6,890
-12,050
-64% -$427K ﹤0.01% 2678
2020
Q2
$715K Buy
18,940
+1,207
+7% +$45.6K ﹤0.01% 2334
2020
Q1
$513K Sell
17,733
-173
-1% -$5.01K ﹤0.01% 2261
2019
Q4
$929K Sell
17,906
-25,277
-59% -$1.31M ﹤0.01% 2235
2019
Q3
$2.37M Buy
43,183
+8,893
+26% +$488K ﹤0.01% 1501
2019
Q2
$1.39M Buy
34,290
+26,324
+330% +$1.07M ﹤0.01% 1891
2019
Q1
$241K Sell
7,966
-1,982
-20% -$60K ﹤0.01% 2999
2018
Q4
$335K Sell
9,948
-90
-0.9% -$3.03K ﹤0.01% 2787
2018
Q3
$424K Buy
10,038
+6,283
+167% +$265K ﹤0.01% 2661
2018
Q2
$120K Sell
3,755
-1,160
-24% -$37.1K ﹤0.01% 3297
2018
Q1
$245K Sell
4,915
-850
-15% -$42.4K ﹤0.01% 2801
2017
Q4
$311K Sell
5,765
-2,728
-32% -$147K ﹤0.01% 2695
2017
Q3
$493K Sell
8,493
-10,462
-55% -$607K ﹤0.01% 2433
2017
Q2
$935K Sell
18,955
-771
-4% -$38K ﹤0.01% 2019
2017
Q1
$856K Sell
19,726
-12,641
-39% -$549K ﹤0.01% 2060
2016
Q4
$1.58M Buy
32,367
+22,101
+215% +$1.08M ﹤0.01% 2035
2016
Q3
$491K Buy
10,266
+1,993
+24% +$95.3K ﹤0.01% 2440
2016
Q2
$444K Sell
8,273
-2,464
-23% -$132K ﹤0.01% 2318
2016
Q1
$480K Buy
10,737
+9,266
+630% +$414K ﹤0.01% 2721
2015
Q4
$56K Sell
1,471
-288
-16% -$11K ﹤0.01% 3996
2015
Q3
$56K Sell
1,759
-841
-32% -$26.8K ﹤0.01% 3490
2015
Q2
$86K Sell
2,600
-124
-5% -$4.1K ﹤0.01% 3358
2015
Q1
$112K Buy
2,724
+598
+28% +$24.6K ﹤0.01% 3329
2014
Q4
$87K Sell
2,126
-3,311
-61% -$135K ﹤0.01% 3749
2014
Q3
$199K Buy
5,437
+1,188
+28% +$43.5K ﹤0.01% 2664
2014
Q2
$197K Buy
4,249
+279
+7% +$12.9K ﹤0.01% 2599
2014
Q1
$163K Sell
3,970
-3,727
-48% -$153K ﹤0.01% 3056
2013
Q4
$294K Buy
7,697
+2,864
+59% +$109K ﹤0.01% 2806
2013
Q3
$116K Sell
4,833
-1,264
-21% -$30.3K ﹤0.01% 3019
2013
Q2
$104K Buy
+6,097
New +$104K ﹤0.01% 3250